This regular update (no. 24 | 13 October 2020) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices

It is more important than ever for private equity firms to be proactive with efforts to mitigate emerging False Claims Act (FCA) and antitrust risks.

Nearly a year after requesting comments on proposed changes to the Hart-Scott-Rodino premerger notification and report form, the Federal Trade Commission and Department of Justice today published the final version of the new form and related final rules.

Orrick Antitrust & Competition partner Jim Tierney moderated a panel on "International Mergers: Working Across Multiple Jurisdictions" at the 2nd edition of the Global Antitrust Economics Conference...

The European Commission has decided that the revised UK support package for EDF’s Hinkley Point C nuclear project is compatible with EU State aid rules.

The CFTC requested comments on proposed amendments to regulations that concern the conditions under which certain non-U.S. entities may qualify for exemptions from registration with the CFTC.

The Hart-Scott-Rodino Act (HSR or HSR Act) requires parties to transactions that meet specified dollar thresholds and do not fall within an exemption to notify the antitrust agencies...

Amanda Hamilton recently had her article "What Can the FTC Do about Orphan Drug Prices?" published in the Antitrust Health Care Chronicle for August 2017.

Article from Waller Law.

The House of Representatives has approved HR 372, the Competitive Health Insurance Reform Act of 2017, which would repeal the antitrust exemption for health insurance companies provided under the McCarran-Ferguson Act ...

In the May 6, 2015, Federal Register, USDA issued a proposal to amend general regulations for federal fruit, vegetable, and specialty crop marketing agreements and marketing orders...

They discuss the precedent set by other cases in this realm and key takeaways about the operation of the regulatory compliance defense in the context of Orange Book antitrust cases in light of recent litigation.

U.S. Eleventh Circuit Court of Appeals

With the holiday marketing season upon us, marketers launch the month-long, relentless scramble for consumer visibility and coveted advertising space on high-traffic inventory. One matter likely not on marketers' radars? Antitrust violations.

We reported previously on DreamWorks Animation's payment of $50 million to settle a class action antitrust suit.

Want to learn more about naming rights deals and the Papa John's controversy.

Like any other business sector, the real estate sector is subject to the rules applicable to merger control.

Jones Day's Chris Pace and Mark Rasmussen discuss the implications of a Florida District Court's decision in United American Corp. v. Bitmain, Inc.

The U.S. DOJ's Antitrust Division and the DOT announced the launch of a broad public inquiry into the state of competition in air travel.

The FTC's record-setting $12 million settlement with Edwards Lifesciences and Genesis MedTech raises critical questions about deal structuring and Hart-Scott-Rodino Act compliance. When does strategic transaction design cross the line into intentional avoidance of premerger notification requirements? Leading antitrust practitioners examine the implications of this landmark enforcement action for deal teams navigating transactions near HSR thresholds.